Literature DB >> 7684936

The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides.

S Volkmann1, J Dannull, K Moelling.   

Abstract

Replication of retroviral RNA into double-stranded DNA provirus involves initiation of plus-strand DNA synthesis at the polypurine tract, PPT, by the reverse transcriptase (RT). The PPT is highly conserved among the known HIV-1 retroviral isolates. It occurs twice, once within the coding region of the integrase and the other one adjacent to the 3' LTR. The data presented show that two antisense oligonucleotides, a 20-mer and a 40-mer, complementary to the PPT induce complete blocks of DNA synthesis whereas an antisense oligonucleotide outside the PPT is only slightly inhibitory. Previously polypurine sequences have been used by several groups for triplex-formation. During replication the HIV-polypurine tract, PPT, is present in a RNA-DNA hybrid. Therefore triple-helix formation consisting of RNA-DNA and a third DNA strand covering the PPT region was tested here by protection against RNase H cleavage in vitro. Incubation with a pyrimidine oligonucleotide in parallel orientation to the PPT-RNA shows some protection. GT-pyrimidine-purine mixed oligonucleotides (25-mer) led to protection against RNase H up to 50% independent of their orientation. The data suggest that triple-helix formation may have taken place with the PPT in vitro. Therefore, this highly conserved structure may prove useful in nucleic acid based anti-viral therapy with antisense or triple-helix approaches. Furthermore, the influence of HIV-1 nucleocapsid (NC) protein, NCp15, on reverse transcription is reported. The data show a two- to three-fold stimulatory effect of the NCp15 on RNA directed DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684936     DOI: 10.1016/0300-9084(93)90027-p

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  8 in total

Review 1.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

2.  Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA.

Authors:  U Koppelhus; V Zachar; P E Nielsen; X Liu; J Eugen-Olsen; P Ebbesen
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

3.  Looped oligonucleotides form stable hybrid complexes with a single-stranded DNA.

Authors:  E Azhayeva; A Azhayev; A Guzaev; J Hovinen; H Lönnberg
Journal:  Nucleic Acids Res       Date:  1995-04-11       Impact factor: 16.971

4.  Sequence-specific DNA double-strand breaks induced by triplex forming 125I labeled oligonucleotides.

Authors:  I G Panyutin; R D Neumann
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

5.  Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro.

Authors:  E Schmalzbauer; B Strack; J Dannull; S Guehmann; K Moelling
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract.

Authors:  W Wu; L E Henderson; T D Copeland; R J Gorelick; W J Bosche; A Rein; J G Levin
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

7.  Inhibition of HIV-1 reverse transcription by triple-helix forming oligonucleotides with viral RNA.

Authors:  S Volkmann; J Jendis; A Frauendorf; K Moelling
Journal:  Nucleic Acids Res       Date:  1995-04-11       Impact factor: 16.971

8.  Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues.

Authors:  J Dannull; A Surovoy; G Jung; K Moelling
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.